{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-019827","form_type":"8-K","ticker":"ZURA","cik":"0001855644","company_name":"Zura Bio Ltd","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.567847+00:00","generated_at":"2026-05-15T23:47:50.310564+00:00","sec_items":["1.01","2.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"confidence":"high","headline":"Zura Bio prices $125M public offering of 18.2M shares at $6.25 and 1.8M pre-funded warrants","bullets":["Offering: 18.2M Class A ordinary shares at $6.25/share, plus 1.8M pre-funded warrants at $6.249 each.","Net proceeds expected ~$134.6M; underwriters' option for 3M additional shares exercised in full.","Preliminary cash and equivalents as of Dec 31, 2025: ~$109.4M.","Total outstanding ordinary shares after offering (excl. pre-funded warrants) ~94.9M.","Offering expected to close Feb 26, 2026; joint bookrunners: Leerink, Piper Sandler, Cantor."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-019827","json":"https://secwatch.observer/filing/0001104659-26-019827.json","markdown":"https://secwatch.observer/filing/0001104659-26-019827.md","text":"https://secwatch.observer/filing/0001104659-26-019827.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855644/000110465926019827/0001104659-26-019827-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855644/000110465926019827/tm267297d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:47:50.310564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}